Booz Allen to pay $377.5 million in settlement over past billing practices
Booz Allen Hamilton Holding Corp. (BAH) said late Friday it has agreed to a $377.5 million settlement with the Justice Department to end a previously disclosed investigation related to the government contractor's past charging practices. Booz Allen said in a filling that the probe was connected to "certain elements of the company's cost accounting and indirect cost charging practices" from April 2011 through March 2021. The company said it will pay the government using cash on hand and also drawing on its revolving credit facility. Booz Allen had recorded a $350 million reserve related to the investigation and had expected the possible loss to be between $350 million and $378 million. "The company entered into the settlement agreement to avoid the delay, uncertainty and expense of protracted litigation" and the agreement contains no admission of liability, Booz Allen said. Shares of Booz Allen were flat in the extended session Friday after ending the regular trading session down 0.4%.
-Claudia Assis
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-21-23 1638ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year